Project cooperationUpdated on 14 January 2026
Connecting Innovation to Cure: Virtual Human Twins Driving the Future of Cancer Research
Grant Writer and Advisor at Research Centre of the Portuguese Oncology Institute of Lisbon Francisco Gentil
Lisbon, Portugal
About
IPO de Lisboa is committed to advancing precision oncology through cutting-edge Virtual Human Twin (VHT) models. As part of the Horizon Europe mission on cancer, we aim to transform patient care by leveraging digital twin technology to predict treatment responses and optimize therapies. We are actively seeking partners to co-develop innovative solutions that accelerate breakthroughs in cancer research.
Our Contribution:
IPO de Lisboa brings unique strengths to this collaboration:
-
Clinical Expertise & Patient Data: Access to real-world oncology data for model development and validation.
-
Research Infrastructure: Advanced facilities for translational cancer research and clinical trials.
-
Validation & Testing: Ability to test VHT models in real clinical settings.
-
Regulatory & Ethical Guidance: Ensuring compliance with EU standards and patient safety.
-
Innovative Concept: A potential idea to create patient-specific digital twins for personalized treatment planning and improved outcomes.
Stage
- Design - setting the project scope
Topic
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
Type
- Consortium/Coordinator seeks Partners
Organisation
Research Centre of the Portuguese Oncology Institute of Lisbon Francisco Gentil
R&D Institution
Lisbon, Portugal
Similar opportunities
Project cooperation
- Offering Expertise to Consortias
- Design - setting the project scope
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
Tânia Cruz
Grant Writer and Advisor at Research Centre of the Portuguese Oncology Institute of Lisbon Francisco Gentil
Lisbon, Portugal
Project cooperation
Facilitating contacts with cancer researchers at Medical University of Vienna
- Completing the consortia
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
Reinhard Eckert
Research Service at Medical University of Vienna
Vienna, Austria
Project cooperation
- Completing the consortia
- Offering Expertise to Consortias
- Design - setting the project scope
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
Dani Ortiz
representador legal at TORMENTA‑IA3, SL
Madrid, Spain